1. Home
  2. NMRA vs AAM Comparison

NMRA vs AAM Comparison

Compare NMRA & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • AAM
  • Stock Information
  • Founded
  • NMRA 2019
  • AAM 2024
  • Country
  • NMRA United States
  • AAM United States
  • Employees
  • NMRA N/A
  • AAM N/A
  • Industry
  • NMRA
  • AAM
  • Sector
  • NMRA
  • AAM
  • Exchange
  • NMRA Nasdaq
  • AAM Nasdaq
  • Market Cap
  • NMRA 424.4M
  • AAM 467.9M
  • IPO Year
  • NMRA 2023
  • AAM 2024
  • Fundamental
  • Price
  • NMRA $2.20
  • AAM $10.60
  • Analyst Decision
  • NMRA Buy
  • AAM
  • Analyst Count
  • NMRA 8
  • AAM 0
  • Target Price
  • NMRA $7.57
  • AAM N/A
  • AVG Volume (30 Days)
  • NMRA 1.9M
  • AAM 40.8K
  • Earning Date
  • NMRA 11-06-2025
  • AAM 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • AAM N/A
  • EPS Growth
  • NMRA N/A
  • AAM N/A
  • EPS
  • NMRA N/A
  • AAM 0.33
  • Revenue
  • NMRA N/A
  • AAM N/A
  • Revenue This Year
  • NMRA N/A
  • AAM N/A
  • Revenue Next Year
  • NMRA N/A
  • AAM N/A
  • P/E Ratio
  • NMRA N/A
  • AAM $32.04
  • Revenue Growth
  • NMRA N/A
  • AAM N/A
  • 52 Week Low
  • NMRA $0.61
  • AAM $10.04
  • 52 Week High
  • NMRA $11.57
  • AAM $10.79
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 41.50
  • AAM 52.30
  • Support Level
  • NMRA $2.55
  • AAM $10.56
  • Resistance Level
  • NMRA $2.78
  • AAM $10.64
  • Average True Range (ATR)
  • NMRA 0.26
  • AAM 0.04
  • MACD
  • NMRA -0.09
  • AAM -0.01
  • Stochastic Oscillator
  • NMRA 10.56
  • AAM 28.57

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: